Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 17330231)

1.

Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.

Farma JM, Puhlmann M, Soriano PA, Cox D, Paciotti GF, Tamarkin L, Alexander HR.

Int J Cancer. 2007 Jun 1;120(11):2474-80.

PMID:
17330231
2.

IsoDGR-tagged albumin: a new αvβ3 selective carrier for nanodrug delivery to tumors.

Curnis F, Sacchi A, Longhi R, Colombo B, Gasparri A, Corti A.

Small. 2013 Mar 11;9(5):673-8. doi: 10.1002/smll.201202310. Epub 2012 Nov 12.

PMID:
23143930
3.
4.

Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.

Powell AC, Paciotti GF, Libutti SK.

Methods Mol Biol. 2010;624:375-84. doi: 10.1007/978-1-60761-609-2_25. Review.

PMID:
20217609
5.

Nanoparticle enhanced thermal therapies.

Shenoi MM, Anderson J, Bischof JC.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1979-82. doi: 10.1109/IEMBS.2009.5333447.

PMID:
19964027
6.

Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.

Nilsson-Ohman J, Fredrikson GN, Nilsson-Berglund LM, Gustavsson C, Bengtsson E, Smith ML, Agardh CD, Agardh E, Jovinge S, Gomez MF, Nilsson J.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1465-70. doi: 10.1161/ATVBAHA.109.193862.

7.

Tumor necrosis factor-alpha potentiates RhoA-mediated monocyte transmigratory activity in vivo at a picomolar level.

Lim S, Ryu J, Shin JA, Shin MJ, Ahn YK, Kim JJ, Han KH.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2138-45. doi: 10.1161/ATVBAHA.109.195735. Epub 2009 Sep 10.

8.

Vasopressin attenuates TNF-mediated inflammation in the rat cremaster microcirculation.

McMahon PJ, Proctor KG.

J Trauma. 2009 Sep;67(3):461-73; discussion 473-5. doi: 10.1097/TA.0b013e3181aa01e4.

PMID:
19741386
9.

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

PMID:
19687708
10.

Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.

Goel R, Shah N, Visaria R, Paciotti GF, Bischof JC.

Nanomedicine (Lond). 2009 Jun;4(4):401-10. doi: 10.2217/nnm.09.21.

11.

Radiation-induced astrogliosis and blood-brain barrier damage can be abrogated using anti-TNF treatment.

Wilson CM, Gaber MW, Sabek OM, Zawaski JA, Merchant TE.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):934-41. doi: 10.1016/j.ijrobp.2009.02.035.

PMID:
19480972
12.

Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.

Mayer ML, Phillips CM, Stadnyk AW, Halperin SA, Lee SF.

Mol Immunol. 2009 May;46(8-9):1883-91. doi: 10.1016/j.molimm.2009.02.008. Epub 2009 Mar 10.

PMID:
19278729
13.

mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.

Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.

Clin Cancer Res. 2009 Mar 1;15(5):1612-22. doi: 10.1158/1078-0432.CCR-08-2057. Epub 2009 Feb 17.

14.

Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis.

Olleros ML, Vesin D, Lambou AF, Janssens JP, Ryffel B, Rose S, Frémond C, Quesniaux VF, Szymkowski DE, Garcia I.

J Infect Dis. 2009 Apr 1;199(7):1053-63. doi: 10.1086/597204.

15.

Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.

Morrison MS, Ricketts SA, Barnett J, Cuthbertson A, Tessier J, Wedge SR.

J Nucl Med. 2009 Jan;50(1):116-22. doi: 10.2967/jnumed.108.056077. Epub 2008 Dec 17.

16.

[Effects of tumor necrosis factor-alpha induced insulin resistance on adipose triglyceride lipase in mice].

Cheng YL, Li L, Yang GY, Shi SC, Chen Y, Zhu W, Sun X.

Zhonghua Yi Xue Za Zhi. 2008 Sep 9;88(34):2417-21. Chinese.

PMID:
19087720
17.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

18.

Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha.

Qin LJ, Gu YT, Zhang H, Xue YX.

Neurosci Lett. 2009 Jan 30;450(2):172-5. doi: 10.1016/j.neulet.2008.10.080. Epub 2008 Oct 28.

PMID:
18983897
19.

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.

Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E, Efimova E, Darga T, Khodarev NN, King CR, Posner MC, Hellman S, Kufe DW, Weichselbaum RR.

Cancer Gene Ther. 2009 Apr;16(4):373-81. doi: 10.1038/cgt.2008.86. Epub 2008 Oct 31.

PMID:
18974777
20.

A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.

Stathopoulos GT, Psallidas I, Moustaki A, Moschos C, Kollintza A, Karabela S, Porfyridis I, Vassiliou S, Karatza M, Zhou Z, Joo M, Blackwell TS, Roussos C, Graf D, Kalomenidis I.

J Natl Cancer Inst. 2008 Oct 15;100(20):1464-76. doi: 10.1093/jnci/djn325. Epub 2008 Oct 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk